Zobrazeno 1 - 10
of 26
pro vyhledávání: '"M V, Rezvantsev"'
Autor:
V. V. Khominets, A. L. Kudyashev, I. S. Bazarov, A. S. Grankin, O. V. Rikun, M. V. Rezvantsev, R. A. Fedorov
Publikováno v:
Travmatologiâ i Ortopediâ Rossii, Vol 26, Iss 4, Pp 32-44 (2020)
Background. In recent years, there has been an increase in the number of the patients with multiligament knee injuries. A significant proportion of unsatisfactory outcomes of such injuries treatment is associated with this injury features and the obj
Externí odkaz:
https://doaj.org/article/76d0617fd39542268fbdd00b07479715
Autor:
A. L. Kudyashev, V. V. Khominets, V. M. Shapovalov, P. A. Metlenko, M. V. Miroevsky, M. V. Rezvantsev, A. V. Teremshonok
Publikováno v:
Travmatologiâ i Ortopediâ Rossii, Vol 23, Iss 1, Pp 132-143 (2017)
Purpose of the study – to design the algorithm of selection for rational surgical tactics for treatment of patients with coxo-vertebral syndrome.Material and methods. 175 patients with coxo-vertebral syndrome were included into the study who underw
Externí odkaz:
https://doaj.org/article/818cd6704910435fa529e3053c8331df
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 9, Iss 1, Pp 50-54 (2017)
Objective: to conduct clinical laboratory studies of spinal muscular atrophy (SMA) for the clarification of the pathogenetic features and role of neurotrophic factors in the formation of polymorphism of this diseasePatients and methods. Thirty-five p
Externí odkaz:
https://doaj.org/article/b986e449786541428f33f1ffed7b7cbe
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 20, Iss 4, Pp 80-84 (2013)
In our study 57 metastatic liver lesions (37 of colorectal and 20 of pancreatic etiology) were examined using high field MR-system (1,5 T). During this investigation quantitative MRI analysis of dynamic contrast enhancement of the hepatic lesions was
Externí odkaz:
https://doaj.org/article/c5dfc2e214124f199ba87871ee8edf81
Autor:
D. Yu. Serdyukov, A. V. Gordienko, V. S. Nikiforov, N. I. Gulyaev, M. V. Rezvantsev, E. A. Starienko
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 2, Pp 16-20 (2012)
Aim. To identify major clinical and ultrasound predictors of heart failure development in patients with subacute myocardial infarction (MI). Material and methods. In total, 135 patients with acute and subacute MI were examined. The assessment of pre-
Externí odkaz:
https://doaj.org/article/6e0e20345b6c4792af8e43c6caf401d5
Publikováno v:
Bulletin of the Russian Military Medical Academy. 20:160-163
The development of mathematical model for predicting forecast successfulness of N.G. Kuznetsov Naval Academy cadets’ professional military adaptation is substantiated. It is established that a group of the most successful cadets has a statistically
Autor:
A.V. Gavrichenko, M G Sokolova, S V Lobzin, E.V. Lopatina, M V Rezvantsev, V.A. Penniyaynen, A. V. Kipenko
Publikováno v:
Biomeditsinskaya Khimiya. 63:453-456
Synaptic pruning is a physiological mechanism of neuroplasticity, which is regulated through synthesis of growth polypeptides, neurotrophins. The role of neurotrophins in the mechanism of synaptic pruning in patients with hereditary pathology of peri
Publikováno v:
Bulletin of the Moscow State Regional University (Natural sciences). :47-56
Publikováno v:
Vestnik severo-zapadnogo gosudarstvennogo medicinskogo universiteta im. I.I. Mečnikova, Vol 6, Iss 4, Pp 45-51 (2014)
Spinal muscle atrophy (SMA) of type 2 is an autosomal-recessive disease defined by a degenerative change in alpha-motor neurons of anterior horns. The disease is manifested in weakness of proximal muscles, pareses, respiratory disturbance and early d
Autor:
I. V. Litvinenko, A V Kiselev, O A Nikishina, S V Lobzin, M V Rezvantsev, A.V. Gavrichenko, M G Sokolova
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 117:78
Clarification of the pathogenesis of cognitive disorders in patients with Duchenne muscular dystrophy in the clinical laboratory and molecular genetic study.Thirty-six male patients with Duchenne muscular dystrophy (DMD), aged from 5 to 22 years (mea